New device aims to ease heart failure symptoms by stimulating blood pressure sensors

NCT ID NCT07335510

Recruiting now Disease control Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests a device called Barostim that is implanted in the body to stimulate blood pressure sensors, which may help the heart work better. It involves 58 adults with heart failure who are already on the best available medications. The goal is to see if the device improves heart function, symptoms, and exercise ability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION

Contacts and locations

Locations

Columbia University Irving Medical Center
RECRUITING

New York, New York, 10032, United States
MedStar Health
NOT_YET_RECRUITING

Washington D.C., District of Columbia, 20010, United States
Medical University of South Carolina Health
NOT_YET_RECRUITING

Charleston, South Carolina, 29425, United States
Montefiore Medical Center
NOT_YET_RECRUITING

New York, New York, 10461, United States
University of California San Francisco Health
NOT_YET_RECRUITING

San Francisco, California, 94143, United States
University of Chicago Medical Center
NOT_YET_RECRUITING

Chicago, Illinois, 15212, United States
Weill Cornell Medicine
NOT_YET_RECRUITING

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.